Upgrade to SI Premium - Free Trial

Pre-Open Stock Movers 11/23: (CANF) (KBIO) (MNK) Higher; (PARR) (CAVM) (AGN) Lower (more...)

November 23, 2015 9:37 AM
Can-Fite BioPharma (NYSE: CANF) 37.6% HIGHER; announced development of its drug candidate CF102, which is currently in Phase II trials ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles